Actavis PLC (ACT.N)
9 Dec 2013
|Market Cap (Mil.):||$28,465.54|
|Shares Outstanding (Mil.):||174.05|
Sept 27 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:
WASHINGTON - Federal regulators on Friday removed a roadblock to drugmaker Actavis Inc's purchase of Warner Chilcott Plc after Actavis agreed to sell all rights and assets related to three oral contraceptives and an osteoporosis treatment.
NEW YORK - Specialty pharmaceutical Warner Chilcott Plc is in market with $4.4 billion in credit facilities that will refinance and combine debt following the company's acquisition by drug manufacturer Actavis Inc , sources told Thomson Reuters LPC.
NEW YORK, July 3 - Specialty pharmaceutical Warner Chilcott Plc is in market with $4.4 billion in credit facilities that will refinance and combine debt following the company's acquisition by drug manufacturer Actavis Inc, sources told Thomson Reuters LPC.
WASHINGTON, June 17 - The U.S. Supreme Court ruled on Monday that the Federal Trade Commission can challenge deals that brand-name drug companies make with generic rivals to keep cheaper products off the market.
Earnings vs. Estimates
Analyst Research Reports
Provider: Directors Deals Ltd.
Provider: ValuEngine, Inc.
Provider: Thomson Reuters Stock Report
Provider: S&P Capital IQ – STARS Reports
Watson Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.